The evaluation of proliferative activity in CIN III and microinvasive cervical cancer and its role in recurrence

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 94, Issue 2, 2001, Pages 270-275

  Tjalma, Wiebren ^a,b   Weyler, Joost ^a   Pollefliet, Christophe ^b   Bogers, Johannes ^b   Van Marck, Eric ^a,b   Van Dam, Peter ^a,b   Buytaert, Philippe ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cervical intraepithelial neoplasia; Mitotic index; PCNA; Recurrence

Indexed keywords

CYCLINE;

ADULT; ARTICLE; CANCER RECURRENCE; CELL PROLIFERATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0035145058     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00333-X     Document Type: Article

References (24)

1. The natural history of cervical intraepithelial neoplasia and management of the abnormal Papanicolaou smear
2. Management of cervical intraepithelial neoplasia
3. Mitosis counting in tumors
4. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the multicenter morphometric mammary carcinoma project
5. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein
6. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta
7. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin
8. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group (EORTC-GCCG)
9. Volume corrected mitotic index (MN index). The standard of mitotic activity in neoplasms
10. Non-parametric estimation from incomplete observations
11. Regression models and life tables
12. A critical evaluation of three methods of studying cell proliferation in human cervical epithelium
13. Immunohistochemical detection of metallothionein and MIBi in uterine cervical squamous lesions
14. Proliferating cell nuclear antigen (cyclin) expression in normal and abnormal cervical squamous epithelia
15. Expression of the proliferating cell nuclear antigen in cervical neoplasia
16. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining
17. MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions
18. Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium
19. Bcl-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia. CIN, and cervical carcinoma
20. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase
21. Comparative study of histologic and chromosomal abnormalities in cervical neoplasia
22. A histological and immunological study of cervical intraepithelial neoplasia in relation to recurrence alter local treatment
23. The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients